NEW YORK, March 21 - Fulfilling its promise, Enzo Diagnostics has filed a patent-infringement suit against Digene that seeks an injunction and monetary damages.
 
Additionally, Enzo Biochem, Enzo Diagnostic's parent, asked the federal district court to dismiss a declaratory judgment suit that Digene filed on March 14. Enzo claims that the suit "incorrectly named" Enzo Biochem as the adverse party, although it claims never to have owned the patent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.